Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 73
  1. Jan 16, 2026 · 17:31 · NGMD

    NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

    NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

    01
  2. Jan 16, 2026 · 16:06 · HEM

    Hemostemix gets FDA support for basket protocol

    Hemostemix gets FDA support for basket protocol

    02
  3. Jan 16, 2026 · 15:22 · CRDL

    Cardiol Therapeutics arranges $13.5-million bought deal

    Cardiol Therapeutics arranges $13.5-million bought deal

    03
  4. Jan 16, 2026 · 12:27 · HEM

    Hemostemix Receives FDA Support for Its Basket Protocol Approach

    Hemostemix Receives FDA Support for Its Basket Protocol Approach

    04
  5. Jan 16, 2026 · 12:06 · FNDX

    Canadian Securities Exchange Reports Strong 2025 Performance Figures

    Canadian Securities Exchange Reports Strong 2025 Performance Figures

    05
  6. Jan 16, 2026 · 11:40 · VPT

    AI Diagnostics: The End of the High-Cost Imaging Era

    AI Diagnostics: The End of the High-Cost Imaging Era

    06
  7. Jan 16, 2026 · 08:42 · CRDL

    Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

    Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

    07
  8. Jan 16, 2026 · 08:00 · EXE

    Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call

    Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call

    08
  9. Jan 16, 2026 · 02:32 · NURS

    Hydreight arranges $10-million bought deal offering

    Hydreight arranges $10-million bought deal offering

    09
  10. Jan 15, 2026 · 19:14 · BUX

    Biomark research to be published in Frontiers

    Biomark research to be published in Frontiers

    10
  11. Jan 15, 2026 · 18:00 · SKNY

    LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies

    LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies

    11
  12. Jan 15, 2026 · 17:45 · MDNA

    Medicenna sets out plans, milestones for 2026

    Medicenna sets out plans, milestones for 2026

    12
  13. Jan 15, 2026 · 17:19 · PRN

    Profound Medical has success at Mount Sinai Hospital

    Profound Medical has success at Mount Sinai Hospital

    13
  14. Jan 15, 2026 · 16:51 · NURS

    Hydreight Announces $10 Million Bought Deal Private Placement

    Hydreight Announces $10 Million Bought Deal Private Placement

    14
← Newer Older →